• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类补体的第九个成分:分离、描述及作用方式

The ninth component of human complement: isolation, description and mode of action.

作者信息

Hadding U, Müller-Eberhard H J

出版信息

Immunology. 1969 Jun;16(6):719-35.

PMID:4182367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1409673/
Abstract

A method is described which permits isolation of C′9 from human serum. The final product was homogeneous by polyacrylamide gel electrophoresis and the distribution of C′9 haemolytic activity corresponded to the position of the protein disc. C′9 is an α-globulin which has a sedimentation coefficient of 4.5S, a diffusion coefficient of 5.1 × 10 cm/sec and a calculated molecular weight of 79,000. The reaction of C′9 with EAC′1∼8 was found to be temperature dependent and to proceed optimally at pH 7. In the course of this reaction C′9 activity declined in the fluid phase and C′9 protein became specifically attached to the cells, as revealed by the use of radioactively labelled C′9. The haemolytic activity of C′9 was mimicked by bipyridine which exhibited the previously reported phenanthroline effect. Kinetic experiments showed that 0.09 M EDTA, which inhibits haemolysis, acts subsequent to the C′9 reaction step. Possible modes of action of C′9 are discussed.

摘要

本文描述了一种从人血清中分离C′9的方法。通过聚丙烯酰胺凝胶电泳,最终产物呈均一性,C′9溶血活性的分布与蛋白质条带的位置相对应。C′9是一种α球蛋白,沉降系数为4.5S,扩散系数为5.1×10 cm/秒,计算分子量为79,000。发现C′9与EAC′1∼8的反应依赖于温度,在pH 7时反应最佳。在该反应过程中,C′9活性在液相中下降,并且如使用放射性标记的C′9所显示的,C′9蛋白特异性地附着于细胞。联吡啶模拟了C′9的溶血活性,表现出先前报道的菲咯啉效应。动力学实验表明,抑制溶血的0.09 M EDTA在C′9反应步骤之后起作用。文中讨论了C′9可能的作用方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f5/1409673/523ae13cb404/immunology00389-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f5/1409673/523ae13cb404/immunology00389-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f5/1409673/523ae13cb404/immunology00389-0036-a.jpg

相似文献

1
The ninth component of human complement: isolation, description and mode of action.人类补体的第九个成分:分离、描述及作用方式
Immunology. 1969 Jun;16(6):719-35.
2
Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.眼镜蛇毒中抗补体蛋白的分离及其对C3的作用方式。
J Immunol. 1971 Dec;107(6):1666-72.
3
The purification and reactivity of the first component of complement from guinea pig, human and canine sera.豚鼠、人及犬血清中补体第一成分的纯化及反应性
J Immunol. 1968 Dec;101(6):1333-45.
4
Complement dependent hemolysis of sheep erythrocytes coupled with non-antibody human IgG.补体依赖的绵羊红细胞溶血作用与非抗体人IgG相结合。
Biken J. 1968 Dec;11(4):261-7.
5
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.眼镜蛇毒中的两种抗补体因子:其中一种可使豚鼠红细胞发生溶血。
J Immunol. 1969 Nov;103(5):944-52.
6
Studies of an additional kindred with hereditary deficiency of the second component of human complement (C2) and description of a new method for the quantitation of C2.人类补体第二成分(C2)遗传性缺陷的另一亲缘家族研究及C2定量新方法的描述。
J Immunol. 1968 Dec;101(6):1176-82.
7
A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect.患有家族性调理素缺陷个体的人血清中补体第五成分(C5)的功能异常。
J Immunol. 1974 Mar;112(3):1164-76.
8
Isolation and characterization of the proenzyme form of the C1r subunit of the first complement component.第一补体成分C1r亚基酶原形式的分离与鉴定
J Immunol. 1974 May;112(5):1667-73.
9
C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.人C3灭活剂。I. 通过细胞结合C3的灭活进行溶血测定。
J Immunol. 1969 Mar;102(3):533-43.
10
The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.豚鼠抗体的生物学活性。II. 补体与γ1和γ2免疫球蛋白的相互作用模式。
J Immunol. 1970 Feb;104(2):329-34.

引用本文的文献

1
The Importance of Complement-Mediated Immune Signaling in Alzheimer's Disease Pathogenesis.补体介导的免疫信号在阿尔茨海默病发病机制中的重要性。
Int J Mol Sci. 2024 Jan 9;25(2):817. doi: 10.3390/ijms25020817.
2
Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity.猪C9补体成分与溶血补体活性的遗传关联。
Asian-Australas J Anim Sci. 2015 Sep;28(9):1354-61. doi: 10.5713/ajas.14.0734.
3
The complement system: history, pathways, cascade and inhibitors.补体系统:历史、途径、级联反应及抑制剂

本文引用的文献

1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
3
STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. I. INHIBITION BY TRISODIUM ETHYLENEDIAMINETETRAACETATE (EDTA).
Eur J Microbiol Immunol (Bp). 2012 Jun;2(2):103-11. doi: 10.1556/EuJMI.2.2012.2.2. Epub 2012 Jun 13.
4
Biological characterization of Chlamydia trachomatis plasticity zone MACPF domain family protein CT153.沙眼衣原体可塑性区 MACPF 结构域家族蛋白 CT153 的生物学特性研究。
Infect Immun. 2010 Jun;78(6):2691-9. doi: 10.1128/IAI.01455-09. Epub 2010 Mar 29.
5
Small angle neutron scattering studies of C8 and C9 and their interactions in solution.C8和C9在溶液中的小角中子散射研究及其相互作用
Biophys J. 1993 Mar;64(3):743-8. doi: 10.1016/S0006-3495(93)81434-6.
6
Membrane attack complex of complement: a structural analysis of its assembly.补体膜攻击复合物:其组装的结构分析
J Exp Med. 1980 Feb 1;151(2):301-13. doi: 10.1084/jem.151.2.301.
7
Human complement in the arachidonic acid transformation pathway in platelets.血小板中花生四烯酸转化途径中的人类补体。
J Exp Med. 1981 Feb 1;153(2):257-68. doi: 10.1084/jem.153.2.257.
8
Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.补体第九成分(C9)的聚合:形成具有类似于补体膜攻击复合物的管状超微结构的多聚(C9)。
Proc Natl Acad Sci U S A. 1982 Jan;79(2):574-8. doi: 10.1073/pnas.79.2.574.
9
Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer.人补体膜攻击复合物C5b-9的分子量:末端复合物作为C5b-9单体的特性
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1818-22. doi: 10.1073/pnas.78.3.1818.
10
Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers.人类补体功能性膜攻击复合物的组装:二硫键连接的C9二聚体的形成。
Proc Natl Acad Sci U S A. 1981 Oct;78(10):6426-30. doi: 10.1073/pnas.78.10.6426.
免疫溶血终末步骤的研究。I. 乙二胺四乙酸三钠(EDTA)的抑制作用
J Immunol. 1964 Sep;93:409-13.
4
STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.人C1酯酶的研究。I. 纯化及酶学性质
J Immunol. 1964 Mar;92:456-67.
5
EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS.低离子强度对免疫溶血的影响
J Immunol. 1963 Dec;91:826-32.
6
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.人补体第四成分的分离与描述
J Exp Med. 1963 Sep 1;118(3):447-66. doi: 10.1084/jem.118.3.447.
7
Chromatographic resolution of the first component of human complement into three activities.将人类补体的第一成分通过色谱法分离为三种活性。
J Exp Med. 1963 Jun 1;117(6):983-1008. doi: 10.1084/jem.117.6.983.
8
A new supporting medium for preparative electrophoresis.一种用于制备电泳的新型支持介质。
Scand J Clin Lab Invest. 1960;12:33-7.
9
Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement.关于补体作用机制。II. 豚鼠补体第一成分的性质。
J Immunol. 1956 Dec;77(6):469-78.
10
Separation and partial purification of the sixth, seventh and eighth components of human haemolytic complement.人溶血性补体第六、七、八成分的分离及部分纯化
Acta Pathol Microbiol Scand. 1967;70(3):469-80. doi: 10.1111/j.1699-0463.1967.tb01315.x.